Characteristics of periventricular nodules in patients with 22q11.2 deletion syndrome
Abstract number :
1.380
Submission category :
12. Genetics / 12A. Human Studies
Year :
2017
Submission ID :
345626
Source :
www.aesnet.org
Presentation date :
12/2/2017 5:02:24 PM
Published date :
Nov 20, 2017, 11:02 AM
Authors :
Arezoo Rezazadeh, Krembil Neuroscience Centre, Toronto Western Hospital, University of Toronto; Eduard Bercovici, University of Toronto, Toronto Western Hospital; Eva Chow, Centre for Addiction and Mental Health and Department of Psychiatry; Rasmus Kiehl,
Rationale: We aimed to identify the prevalence and distribution of periventricular nodular heterotopia (PNH) in patients with 22q11.2 microdeletion syndrome (22q11.2DS). Methods: We retrospectively analyzed the data of 35 adult patients with 22q11.2DS. Patients without brain MRI or with poor quality images were excluded from the study. We also included 2 other patients with PNH identified through postmortem study, previously reported by our group. 22q11.2 microdeletion was confirmed by FISH analysis other pathologic genetic findings were ruled out through genome-wide microarray or whole genome sequencing. Results: Out of 30 patients who met study entry criteria, 7 had PNH. Out of these 7 patients, two patients did not have seizures. In the remainder, the mean age of seizure onset was 14.4 (2-42) years. The nodules were located over the frontal horn of lateral ventricles, in all 7 patients. The nodules were small, non-contiguous, varying in number from 1 to10. They were unilateral in 5/7 patients. Conclusions: Our study demonstrates that PNH in patients with 22q11.2DS have a characteristic pattern: small number, small size, non-contiguous, and located over the frontal horn of the lateral ventricles. This finding may help diagnosis in patients who do not have genetic testing. Furthermore, the description of these 7 patients, make 22q11.2 microdeletion the 3rd most common CNV reported to date in association with PNH (after 6q terminal deletion and 17q21.3 deletion). Funding: Brain and behaviour foundation (DMA)
Genetics